1-4 of 4
PierMannuccio Mannucci
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Risk Stratification to Minimize Inhibitor Risk with the Use of Recombinant Factor VIII Concentrates: A Sippet Analysis

Frits Rosendaal, MD PhD, Roberta Palla, PhD, Isabella Garagiola, PhD, Piermannuccio Mannucci, MD, Flora Peyvandi, MD PhD
Journal: Blood
Blood (2016) 128 (22): 325.
https://doi.org/10.1182/blood.V128.22.325.325
Published: 2016
Journal Articles

Risk Differential in Inhibitor Development in the First Days of Treatment By Product Class: A Sippet Analysis

Flora Peyvandi, MD PhD, Antonino Cannavò, MD, Isabella Garagiola, PhD, Roberta Palla, PhD, Frits Rosendaal, MD PhD, Piermannuccio Mannucci, MD
Journal: Blood
Blood (2016) 128 (22): 330.
https://doi.org/10.1182/blood.V128.22.330.330
Published: 2016
Journal Articles

Patient Preferences for Treatment Products in Hemophilia: A Conjoint Analysis (Conan Study Group).

Alessandro Gringeri, MD, MSc, Piermannuccio Mannucci, MD, Mara Monzini, PharmD, Luciana Scalone, PharmD, Lorenzo Mantovani, MSc, DSc
Journal: Blood
Blood (2004) 104 (11): 2203.
https://doi.org/10.1182/blood.V104.11.2203.2203
Published: 2004
Journal Articles

Hyperprothrombinemia may result in acquired activated protein C resistance

Armando Tripodi, Veena Chantarangkul, PierMannuccio Mannucci
Journal: Blood
Blood (2000) 96 (9): 3295–3296.
https://doi.org/10.1182/blood.V96.9.3295
Published: 2000